[1] Qian JQ,Sun P,Pan ZY,et al.Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines[J].Int J Clin Exp Pathol,2015,8(9):11934-11944. [2] Chan JY,Siu KP,Fung KP,et al.Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells[J].Cancer Lett,2006,236(2):250-258. [3] 李友建,夏俊,赵锐,等.三氧化二砷对人乳腺癌SKBR-3细胞增殖及Notch1表达的影响[J].中国中西医结合杂志,2012,32(6):793-796. [4] Huang X,Ma J,Xu J,et al.Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch 1 expression[J].Mol Med Rep,2015,11(3):2334-2340. [5] Hu J,Huang X,Hong X,et al.Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway[J].Cancer Cell Int,2013,13(1):25. [6] Zhao H,Guo W,Peng C,et al.Arsenic trioxide inhibits the growth of Adriamycin resistant osteosarcoma cells through inducing apoptosis[J].Mol Biol Rep,2010,37(5):2509-2515. [7] Chakravarty G,Mathur A,Mallade P,et al.Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells[J].Biochimie,2016,124:53-64. [8] Waxman S,Anderson KC.History of the development of arsenic derivatives in cancer therapy[J].Oncologist,2001,6(Suppl 2):3-10. [9] Li H,Zhu X,Zhang Y,et al.Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction[J].J Exp Clin Cancer Res,2009,28:110. [10] Wang Y,An R,Dong X,et al.Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells[J].Urol Int,2009,82(2):214-221. [11] Yu J,Qian H,Li Y,et al.Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction[J].Cancer Biol Ther,2007,6(4):580-586. [12] He X,Yang K,Chen P,et al.Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients:a meta-analysis and systematic review[J].Oncol Targets Ther,2014,7(default):1593-1599. [13] Chen J,Cheng J,Yi J,et al.Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide[J].Leuk Res,2016,50:116-122. [14] Zhao D,Jiang Y,Dong X,et al.Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms[J].Biomed Pharmacother,2011,65(5):354-358. [15] Zhao H,Guo W,Peng C,et al.Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis[J].Mol Biol Rep,2010,37(5):2509-2515. [16] Komoto C,Nakamura T,Yamamori M,et al.Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA[J].Kobe J Med Sci,2008,53(6):355-363. [17] Liu J,Shen JX,Wen XF,et al.Targeting Notch degradation system provides promise for breast cancer therapeutics[J].Crit Rev Oncol Hematol,2016,104:21-29. [18] Rizzo P,Miao H,D'Souza G,et al.Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches[J].Cancer Res,2008,68(13):5226-5235. [19] Meng RD,Shelton CC,Li YM,et al.gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity[J].Cancer Res,2009,69(2):573-582. [20] 刘海艳,沈莉菁,陈芳源,等.三氧化二砷对Molt-4细胞株Notch信号通路作用机制的研究[J].内科理论与实践,2015,10(1):35-40. [21] Hsu SY,Hsueh AJ.Tissue-specific Bcl-2 protein partners in apoptosis:An ovarian paradigm[J].Physiol Rev,2000,80(2):593-614. [22] Lin J,Page C,Jin X,et al.Suppression activity of pro-apoptotic gene products in cancer cells,a potential application for cancer gene therapy[J].Anticancer Res,2001,21(2A):831-839. [23] Zhang T,Wang SS,Hong L,et al.Arsenic trioxide induces apoptosis of rat hepatocellularcarcinoma cells in vivo[J].J Exp Clin Cancer Res,2003,22(1):61-68. |